BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
3.990
-0.080 (-1.97%)
May 13, 2025, 4:00 PM - Market closed

BioAge Labs Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
257.49354.3521.6427.64
Cash & Short-Term Investments
320.52354.3521.6427.64
Cash Growth
84.21%1537.17%-21.70%-
Prepaid Expenses
2.832.750.350.39
Restricted Cash
--3.31-
Total Current Assets
324.81357.125.3128.03
Property, Plant & Equipment
4.130.790.520.37
Long-Term Investments
14.660.10.1-
Other Long-Term Assets
0.240.24-0.03
Total Assets
343.84358.2325.9228.43
Accounts Payable
3.9921.872.26
Accrued Expenses
4.3111.336.553.36
Short-Term Debt
--38.86-
Current Portion of Long-Term Debt
6660.17
Current Portion of Leases
0.70.20.190.05
Current Unearned Revenue
8.187.833.31-
Other Current Liabilities
0.560.421.390.02
Total Current Liabilities
23.7427.7858.175.86
Long-Term Debt
1.062.58.22.25
Long-Term Unearned Revenue
3.234.67--
Other Long-Term Liabilities
0.10.160.230.15
Total Liabilities
30.6735.1166.68.27
Additional Paid-In Capital
578.64575.698.145.12
Retained Earnings
-265.74-252.81-181.7-117.85
Comprehensive Income & Other
0.260.250.160.17
Total Common Equity
313.17323.13-173.4-112.56
Shareholders' Equity
313.17323.13-40.6720.16
Total Liabilities & Equity
343.84358.2325.9228.43
Total Debt
10.318.753.252.47
Net Cash (Debt)
324.77345.65-31.6125.18
Net Cash Per Share
16.8532.22-18.9015.06
Filing Date Shares Outstanding
35.8535.851.671.67
Total Common Shares Outstanding
35.8535.851.671.67
Working Capital
301.08329.33-32.8622.17
Book Value Per Share
8.749.01-103.62-67.33
Tangible Book Value
313.17323.13-173.4-112.56
Tangible Book Value Per Share
8.749.01-103.62-67.33
Machinery
1.170.790.740.58
Construction In Progress
0.050.18--
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q